Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 578153

Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants


Perković, Ivana; Butula, Ivan; Kralj, Marijeta; Martin-Kleiner, Irena; Balzarini, Jan; Hadjipavlou-Litina, Dimitra; Katsori, Anna-Maria; Zorc, Branka
Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants // European journal of medicinal chemistry, 51 (2012), 227-238 doi:10.1016/j.ejmech.2012.02.046 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 578153 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants

Autori
Perković, Ivana ; Butula, Ivan ; Kralj, Marijeta ; Martin-Kleiner, Irena ; Balzarini, Jan ; Hadjipavlou-Litina, Dimitra ; Katsori, Anna-Maria ; Zorc, Branka

Izvornik
European journal of medicinal chemistry (0223-5234) 51 (2012); 227-238

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
NSAID; Semicarbazide; Carbazide; Cytostatic activity; Lipoxygenase; Lipid peroxidation

Sažetak
The novel 1-acyl-4-cycloalkyl/arylsemicarbazides (5a-y) and 1-acyl-5-benzyloxy/hydroxy carbamoylcarbazides (8a-f) derived from the nonsteroidal anti-inflammatory drugs ibuprofen, fenoprofen and reduced ketoprofen were prepared, fully chemically characterized and evaluated for their cytostatic, antiviral and antioxidant activities. Compounds 5 and 8 consist of a region rich in electronegative atoms (five to nine nitrogen and oxygen atoms) framed by aryl or cycloalkyl residues on one or both terminal ends. The synthetic pathways applied for the preparation of the title compounds involved a benzotriazole as a synthetic auxiliary in several steps. Three of the tested compounds, namely 4- benzhydryl-1-[2-(3-phenoxyphenyl)propanoyl]semicarbazide (5l), 4-benzhydryl-1-[2-(3-benzylphenyl)propanoyl]semicarbazide (5s), and 4-benzhydryl-1-[2-(4-isobutylphenyl)propanoyl]semicarbazide (5f)showed pronounced antiproliferative activity in vitro against six cancer cell lines (IC50=3-23 uM). The same compounds highly inhibited soybean lipoxygenase (IC50=60 and 51.5 uM) and lipid peroxidation as well (99, 88 and 74%, respectively). 4-Benzyloxy-1-[2-(4-isobutylphenyl)propanoyl]semicarbazide (5t) and 5-benzyloxycarbamoyl-1-[2-(3-benzylphenyl)propanoyl]carbazide (8c) exerted complete lipid peroxidation inhibition. Semicarbazides 5wey and carbazides 8def bearing a hydroxamic acid/hydroxyurea moiety showed a modest antiradical activity in DPPH test, while the best radical scavenger was 1-(1-benzotriazolecarbonyl)-4-benzyloxysemicarbazide (7). None of the compounds were inhibitory to a broad panel of DNA and RNA viruses in the cell culture at subtoxic concentrations. 

Izvorni jezik
Engleski

Znanstvena područja
Kemija, Temeljne medicinske znanosti, Farmacija



POVEZANOST RADA


Projekti:
098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
006-0000000-3216 - Sinteza, karakterizacija i djelovanje potencijalnih i poznatih ljekovitih tvari (Zorc, Branka, MZOS ) ( CroRIS)

Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com ac.els-cdn.com dx.doi.org

Citiraj ovu publikaciju:

Perković, Ivana; Butula, Ivan; Kralj, Marijeta; Martin-Kleiner, Irena; Balzarini, Jan; Hadjipavlou-Litina, Dimitra; Katsori, Anna-Maria; Zorc, Branka
Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants // European journal of medicinal chemistry, 51 (2012), 227-238 doi:10.1016/j.ejmech.2012.02.046 (međunarodna recenzija, članak, znanstveni)
Perković, I., Butula, I., Kralj, M., Martin-Kleiner, I., Balzarini, J., Hadjipavlou-Litina, D., Katsori, A. & Zorc, B. (2012) Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants. European journal of medicinal chemistry, 51, 227-238 doi:10.1016/j.ejmech.2012.02.046.
@article{article, author = {Perkovi\'{c}, Ivana and Butula, Ivan and Kralj, Marijeta and Martin-Kleiner, Irena and Balzarini, Jan and Hadjipavlou-Litina, Dimitra and Katsori, Anna-Maria and Zorc, Branka}, year = {2012}, pages = {227-238}, DOI = {10.1016/j.ejmech.2012.02.046}, keywords = {NSAID, Semicarbazide, Carbazide, Cytostatic activity, Lipoxygenase, Lipid peroxidation}, journal = {European journal of medicinal chemistry}, doi = {10.1016/j.ejmech.2012.02.046}, volume = {51}, issn = {0223-5234}, title = {Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants}, keyword = {NSAID, Semicarbazide, Carbazide, Cytostatic activity, Lipoxygenase, Lipid peroxidation} }
@article{article, author = {Perkovi\'{c}, Ivana and Butula, Ivan and Kralj, Marijeta and Martin-Kleiner, Irena and Balzarini, Jan and Hadjipavlou-Litina, Dimitra and Katsori, Anna-Maria and Zorc, Branka}, year = {2012}, pages = {227-238}, DOI = {10.1016/j.ejmech.2012.02.046}, keywords = {NSAID, Semicarbazide, Carbazide, Cytostatic activity, Lipoxygenase, Lipid peroxidation}, journal = {European journal of medicinal chemistry}, doi = {10.1016/j.ejmech.2012.02.046}, volume = {51}, issn = {0223-5234}, title = {Novel NSAID 1-acyl-4-cycloalkyl/arylsemicarbazides and 1-acyl-5-benzyloxy/ hydroxy carbamoylcarbazides as potential anticancer agents and antioxidants}, keyword = {NSAID, Semicarbazide, Carbazide, Cytostatic activity, Lipoxygenase, Lipid peroxidation} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font